Veracyte Inc (VCYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 140,636 | 131,872 | 130,164 | 114,473 | 118,632 |
| Cost of Goods | 38,663 | 40,590 | 40,395 | 34,965 | 39,878 |
| Gross Profit | 101,973 | 91,282 | 89,769 | 79,508 | 78,754 |
| Operating Expenses | 65,441 | 68,926 | 95,432 | 77,569 | 75,457 |
| Operating Income | 37,195 | 22,946 | -5,268 | 2,904 | 4,175 |
| Other Income | 3,439 | -4,057 | 6,518 | 4,524 | -732 |
| Pre-tax Income | 40,634 | 18,889 | 1,250 | 7,428 | 3,443 |
| Income Tax | -515 | -248 | 2,230 | 381 | -1,670 |
| Net Income Continuous | 41,149 | 19,137 | -980 | 7,047 | 5,113 |
| Net Income | $41,149 | $19,137 | $-980 | $7,047 | $5,113 |
| EPS Basic Total Ops | 0.52 | 0.24 | -0.01 | 0.09 | 0.07 |
| EPS Basic Continuous Ops | 0.52 | 0.24 | -0.01 | 0.09 | 0.07 |
| EPS Diluted Total Ops | 0.50 | 0.24 | -0.01 | 0.09 | 0.07 |
| EPS Diluted Continuous Ops | 0.51 | 0.24 | -0.01 | 0.09 | 0.07 |
| EPS Diluted Before Non-Recurring Items | 0.40 | 0.38 | 0.31 | 0.18 | 0.24 |
| EBITDA(a) | $41,842 | $25,593 | $221 | $8,266 | $10,074 |